ROCKWELL MEDICAL, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ROCKWELL MEDICAL, INC. (RMTI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 75.62 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-31
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was -208.48B shares.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 71.81B shares, a 12.56% increase year-over-year.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 69.43M shares, a 19.26% increase year-over-year.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 67.52M shares, a 18.25% increase year-over-year.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 75.62M shares, a 24.14% increase from fiscal 2019.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 60.92M shares, a 15.32% increase from fiscal 2018.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 52.82M shares, a 3.44% increase from fiscal 2017.
- ROCKWELL MEDICAL, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 51.07M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | -208.48B shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -68.33B shares derived: average of 2 quarters · filed 2021-03-31 | -45.53B shares derived: average of 3 quarters · filed 2021-03-31 | 75.62M shares 10-K · filed 2021-03-31 | ||
| 2020-09-30 | 71.81B shares 10-Q · filed 2020-11-09 | 35.94B shares derived: average of 2 quarters · filed 2020-11-09 | 69.59B shares 10-Q · filed 2020-11-09 | -26.75B shares derived: average of 4 quarters · filed 2021-03-31 | ||
| 2020-06-30 | 69.43M shares 10-Q · filed 2020-08-10 | 68.47M shares 10-Q · filed 2020-08-10 | -59.60B shares derived: average of 3 quarters · filed 2021-03-31 | -28.75B shares derived: average of 4 quarters · filed 2021-03-31 | ||
| 2020-03-31 | 67.52M shares 10-Q · filed 2020-05-11 | -89.44B shares derived: average of 2 quarters · filed 2021-03-31 | -38.36B shares derived: average of 3 quarters · filed 2021-03-31 | -28.75B shares derived: average of 4 quarters · filed 2021-03-31 | ||
| 2019-12-31 | -178.94B shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -57.57B shares derived: average of 2 quarters · filed 2021-03-31 | -38.36B shares derived: average of 3 quarters · filed 2021-03-31 | 60.92M shares 10-K · filed 2021-03-31 | ||
| 2019-09-30 | 63.80B shares 10-Q · filed 2020-11-09 | 63.80M shares 10-Q · filed 2019-11-12 | 31.93B shares derived: average of 2 quarters · filed 2020-11-09 | 59.73B shares 10-Q · filed 2020-11-09 | 59.73M shares 10-Q · filed 2019-11-12 | 15.99B shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 58.22M shares 10-Q · filed 2020-08-10 | 57.66M shares 10-Q · filed 2020-08-10 | 57.58M shares derived: average of 3 quarters · filed 2020-08-10 | 56.01M shares derived: average of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | 57.10M shares 10-Q · filed 2020-05-11 | 57.27M shares derived: average of 2 quarters · filed 2020-05-11 | 55.27M shares derived: average of 3 quarters · filed 2020-05-11 | 54.28M shares derived: average of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | 57.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | 54.36M shares derived: average of 2 quarters · filed 2020-03-17 | 53.34M shares derived: average of 3 quarters · filed 2020-03-17 | 52.82M shares 10-K · filed 2020-03-17 | ||
| 2018-09-30 | 51.29M shares 10-Q · filed 2019-11-12 | 51.29M shares derived: average of 2 quarters · filed 2019-11-12 | 51.29M shares 10-Q · filed 2019-11-12 | 51.29M shares derived: average of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | 51.29M shares 10-Q · filed 2019-08-09 | 51.29M shares 10-Q · filed 2019-08-09 | 51.29M shares derived: average of 3 quarters · filed 2019-08-09 | 51.28M shares derived: average of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | 51.29M shares 10-Q · filed 2019-05-10 | 51.29M shares derived: average of 2 quarters · filed 2019-05-10 | 51.28M shares derived: average of 3 quarters · filed 2019-05-10 | 51.22M shares derived: average of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | 51.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 51.27M shares derived: average of 2 quarters · filed 2019-03-18 | 51.19M shares derived: average of 3 quarters · filed 2019-03-18 | 51.07M shares 10-K · filed 2019-03-18 | ||
| 2017-09-30 | 51.26M shares 10-Q · filed 2018-11-09 | 51.15M shares derived: average of 2 quarters · filed 2018-11-09 | 51.00M shares 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | 51.03M shares 10-Q · filed 2018-08-14 | 50.86M shares 10-Q · filed 2018-08-14 | ||||
| 2017-03-31 | 50.69M shares 10-Q/A · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |